TriSalus Life Sciences (NASDAQ:TLSIW) Stock Price Crosses Above 50 Day Moving Average – What’s Next?

Shares of TriSalus Life Sciences, Inc. (NASDAQ:TLSIW) crossed above its 50-day moving average during trading on Thursday. The stock has a 50-day moving average of $0.87 and traded as high as $0.9399. TriSalus Life Sciences shares last traded at $0.9420, with a volume of 1,810 shares.

TriSalus Life Sciences Trading Up 16.3%

The stock has a 50-day moving average price of $0.87 and a 200 day moving average price of $0.97.

Institutional Inflows and Outflows

An institutional investor recently bought a new stake in TriSalus Life Sciences stock. State Street Corp purchased a new position in shares of TriSalus Life Sciences, Inc. (NASDAQ:TLSIW) during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 610,963 shares of the company’s stock, valued at approximately $2,780,000.

TriSalus Life Sciences Company Profile

TriSalus Life Sciences is a medical technology and therapeutics company focused on improving treatment delivery for patients with solid tumors, particularly tumors in the liver and pancreas. Its approach combines proprietary drug-delivery technology with the development of immunotherapies.

The company’s TriNav® infusion system is designed to deliver therapies into tumors using its Pressure-Enabled Drug Delivery (PEDD) approach. TriSalus is also developing investigational therapies intended to work alongside its delivery platform; these therapies are not established treatments.

TriSalus became a publicly traded company in 2023 through a business combination with MedTech Acquisition Corporation.